Clinical Trial Update: COLON ERDERLY LOW DOSE

View source ↗

Summary

Clinical trial update indicates a colon adenocarcinoma study is not yet recruiting. The sponsor listed is Matteo Clavarezza.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma

Snippet

Sponsor: Matteo Clavarezza | Conditions: Colon Adenocarcinoma | Status: NOT_YET_RECRUITING